What Is Causing G1 Therapeutics Inc. (GTHX) Stock To rising In aftermarket Trading?

G1 Therapeutics, Inc. (Nasdaq: GTHX) a commercial-stage biopharmaceutical company specializing in the discovery, development and delivery of next generation therapies that enhance the lives of patients affected with cancer, announced corporate and financial update for the first quarter completed on March 31, 2021. GTHX stock increased substantially adjacent to the news. At last check in […]

News IMC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.